Articles related to VENOUS THROMBOEMBOLISM (VTE)

Pediatric pharmacists recorded 1,130 antithrombotic-related interventions involving 26.4% of 2,264 critically ill children across 9 U.S. children’s hospitals during 697 shifts from July 2023 to November 2024, with 74.7% of those interventions occurring in the pediatric cardiac ICU and 90.4% of initiation and management interventions involving anticoagulant agents.

A Cook County jury awarded $66 million after a 39-year-old patient died from unrecognized internal bleeding following a combined abdominoplasty and liposuction, spotlighting the compounding risks of combined cosmetic procedures.

“This guideline is a road map to help clinicians navigate these advances for the safest and most effective approaches to care.” — Mark A. Creager, MD, Dartmouth Health

Managing venous thromboembolism effectively demands a nuanced understanding of updated clinical guidelines, which now differentiate treatment protocols based on specific risk assessments and patient comorbidities.

For patients with cirrhosis facing venous thromboembolic events, the choice of anticoagulant—be it DOACs or LMWH—demands careful consideration of their unique hemostatic profile, emphasizing the need for personalized treatment strategies.

Venous thromboembolism presents a significant challenge in cancer care, with emerging evidence supporting the use of direct oral anticoagulants for improved outcomes. This highlights the evolving landscape of VTE management in oncology, stressing the importance of personalized treatment strategies.